Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology

Secondary immunodeficiencies (SIDs) are acquired conditions that may occur as sequelae of immune therapy. In recent years a number of disease-modifying therapies (DMTs) has been approved for multiple sclerosis and related disorders such as neuromyelitis optica spectrum disorders, some of which are f...

Descripción completa

Detalles Bibliográficos
Autores principales: Szepanowski, Fabian, Warnke, Clemens, Meyer zu Hörste, Gerd, Mausberg, Anne K., Hartung, Hans-Peter, Kleinschnitz, Christoph, Stettner, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520462/
https://www.ncbi.nlm.nih.gov/pubmed/34657228
http://dx.doi.org/10.1007/s40263-021-00863-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520462/
https://www.ncbi.nlm.nih.gov/pubmed/34657228
http://dx.doi.org/10.1007/s40263-021-00863-4

Ejemplares similares